Literature DB >> 9770641

Amyloid beta-peptide (1-40)-mediated oxidative stress in cultured hippocampal neurons. Protein carbonyl formation, CK BB expression, and the level of Cu, Zn, and Mn SOD mRNA.

M Y Aksenov1, M V Aksenova, W R Markesbery, D A Butterfield.   

Abstract

Mechanism of amyloid beta-peptide (A beta) toxicity in cultured neurons involves the development of oxidative stress in the affected cells. A significant increase in protein carbonyl formation was detected in cultured hippocampal neurons soon after the addition of preaggregated A beta(1-40), indicating oxidative damage of proteins. We report that neurons, subjected to A beta(1-40), respond to A beta oxidative impact by activation of antioxidant defense mechanisms and alternative ATP-regenerating pathway. The study demonstrates an increase of Mn SOD gene expression and the restoration of Cu, Zn SOD gene expression to a normal level after temporary suppression. Partial loss of creatine kinase (CK) BB activity, which is the key enzyme for functioning of the creatine/phosphocreatine shuttle, was compensated in neurons surviving the A beta oxidative attack by increased production of the enzyme. As soon as the oxidative attack triggered by the addition of preaggregated A beta (1-40) to rat hippocampal cell cultures has been extinguished, CK BB expression and SOD isoenzyme-specific mRNA levels in surviving neurons return to normal. We propose that the maintenance of a constant level of CK function by increased CK BB production together with the induction of antioxidant enzyme gene expression in A beta-treated hippocampal neurons accounts for at least part of their adaptation to A beta toxicity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9770641     DOI: 10.1007/BF02761773

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  54 in total

1.  Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons.

Authors:  J F Kelly; K Furukawa; S W Barger; M R Rengen; R J Mark; E M Blanc; G S Roth; M P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  Beta-amyloid neurotoxicity in vitro: evidence of oxidative stress but not protection by antioxidants.

Authors:  C J Pike; N Ramezan-Arab; C W Cotman
Journal:  J Neurochem       Date:  1997-10       Impact factor: 5.372

Review 3.  The creatine-creatine phosphate energy shuttle.

Authors:  S P Bessman; C L Carpenter
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

4.  Increased antioxidant enzyme activity in amyloid beta protein-resistant cells.

Authors:  Y Sagara; R Dargusch; F G Klier; D Schubert; C Behl
Journal:  J Neurosci       Date:  1996-01-15       Impact factor: 6.167

5.  Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death.

Authors:  M S Shearman; C I Ragan; L L Iversen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

6.  Deposits of A beta fibrils are not toxic to cortical and hippocampal neurons in vitro.

Authors:  J R Wujek; M D Dority; R C Frederickson; K R Brunden
Journal:  Neurobiol Aging       Date:  1996 Jan-Feb       Impact factor: 4.673

7.  Amyloid beta protein potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels: a possible involvement of free radicals.

Authors:  K Ueda; S Shinohara; T Yagami; K Asakura; K Kawasaki
Journal:  J Neurochem       Date:  1997-01       Impact factor: 5.372

8.  Amyloid peptides are toxic via a common oxidative mechanism.

Authors:  D Schubert; C Behl; R Lesley; A Brack; R Dargusch; Y Sagara; H Kimura
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

9.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.

Authors:  D Games; D Adams; R Alessandrini; R Barbour; P Berthelette; C Blackwell; T Carr; J Clemens; T Donaldson; F Gillespie
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

10.  The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides.

Authors:  M S Shearman; S R Hawtin; V J Tailor
Journal:  J Neurochem       Date:  1995-07       Impact factor: 5.372

View more
  14 in total

1.  Direct cleavage of AMPA receptor subunit GluR1 and suppression of AMPA currents by caspase-3: implications for synaptic plasticity and excitotoxic neuronal death.

Authors:  Chengbiao Lu; Weiming Fu; Guy S Salvesen; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

2.  Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome.

Authors:  Giovanna Cenini; Amy L S Dowling; Tina L Beckett; Eugenio Barone; Cesare Mancuso; Michael Paul Murphy; Harry Levine; Ira T Lott; Frederick A Schmitt; D Allan Butterfield; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2011-10-08

3.  Extracellular superoxide dismutase in cultured astrocytes: decrease in cell-surface activity and increase in medium activity by lipopolysaccharide-stimulation.

Authors:  Ichiro Iitsuka; Akiko Motoyoshi-Yamashiro; Mitsuaki Moriyama; Yukiko Kannan-Hayashi; Yuka Fujimoto; Katsura Takano; Koji Murakami; Yukio Yoneda; Yoichi Nakamura
Journal:  Neurochem Res       Date:  2012-06-28       Impact factor: 3.996

4.  Trigonelline protects hippocampus against intracerebral Aβ(1-40) as a model of Alzheimer's disease in the rat: insights into underlying mechanisms.

Authors:  Javad Fahanik-Babaei; Tourandokht Baluchnejadmojarad; Farnaz Nikbakht; Mehrdad Roghani
Journal:  Metab Brain Dis       Date:  2018-11-12       Impact factor: 3.584

5.  Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease.

Authors:  Wycliffe O Opii; Gururaj Joshi; Elizabeth Head; N William Milgram; Bruce A Muggenburg; Jon B Klein; William M Pierce; Carl W Cotman; D Allan Butterfield
Journal:  Neurobiol Aging       Date:  2006-10-20       Impact factor: 4.673

6.  Temporal relations among amyloid beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses.

Authors:  S M Yatin; M Aksenova; M Aksenov; W R Markesbery; T Aulick; D A Butterfield
Journal:  J Mol Neurosci       Date:  1998-12       Impact factor: 3.444

Review 7.  The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.

Authors:  D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2014-07-01       Impact factor: 7.376

Review 8.  The glutamatergic system and Alzheimer's disease: therapeutic implications.

Authors:  D Allan Butterfield; Chava B Pocernich
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 9.  Oxidative stress in Alzheimer's disease: Primary villain or physiological by-product?

Authors:  Greg T Sutherland; Belal Chami; Priscilla Youssef; Paul K Witting
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

10.  Melatonin in Alzheimer's disease and other neurodegenerative disorders.

Authors:  V Srinivasan; S R Pandi-Perumal; D P Cardinali; B Poeggeler; R Hardeland
Journal:  Behav Brain Funct       Date:  2006-05-04       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.